West Pharmaceutical Services, Inc. (BMV:WST)
4,298.50
+58.53 (1.38%)
At close: Jun 9, 2025
BMV:WST Ratios and Metrics
Market cap in millions MXN. Fiscal year is January - December.
Millions MXN. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 6, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 296,414 | 494,319 | 440,454 | 339,868 | 712,272 | 416,758 | Upgrade
|
Market Cap Growth | -31.09% | 12.23% | 29.60% | -52.28% | 70.91% | 98.65% | Upgrade
|
Enterprise Value | 294,564 | 490,505 | 430,449 | 331,498 | 704,638 | 412,980 | Upgrade
|
Last Close Price | 4298.50 | 6396.72 | 6597.09 | 6715.26 | 9545.75 | - | Upgrade
|
PE Ratio | 31.04 | 48.15 | 43.91 | 29.74 | 52.50 | 60.50 | Upgrade
|
PS Ratio | 5.01 | 8.20 | 8.83 | 6.04 | 12.27 | 9.76 | Upgrade
|
PB Ratio | 5.41 | 8.84 | 9.04 | 6.49 | 14.88 | 11.29 | Upgrade
|
P/TBV Ratio | 5.65 | 9.25 | 9.45 | 6.81 | 15.78 | 12.23 | Upgrade
|
P/FCF Ratio | 47.25 | 85.83 | 62.86 | 39.65 | 105.09 | 70.26 | Upgrade
|
P/OCF Ratio | 21.82 | 36.31 | 33.55 | 24.07 | 59.49 | 44.33 | Upgrade
|
EV/Sales Ratio | 5.32 | 8.14 | 8.63 | 5.89 | 12.14 | 9.67 | Upgrade
|
EV/EBITDA Ratio | 19.06 | 31.43 | 30.19 | 19.22 | 38.58 | 39.03 | Upgrade
|
EV/EBIT Ratio | 25.24 | 39.66 | 36.05 | 22.25 | 44.72 | 49.11 | Upgrade
|
EV/FCF Ratio | 46.96 | 85.17 | 61.43 | 38.68 | 103.97 | 69.62 | Upgrade
|
Debt / Equity Ratio | 0.12 | 0.11 | 0.11 | 0.12 | 0.14 | 0.18 | Upgrade
|
Debt / EBITDA Ratio | 0.39 | 0.39 | 0.35 | 0.35 | 0.36 | 0.60 | Upgrade
|
Debt / FCF Ratio | 1.00 | 1.11 | 0.75 | 0.72 | 0.98 | 1.11 | Upgrade
|
Asset Turnover | 0.80 | 0.77 | 0.79 | 0.83 | 0.93 | 0.84 | Upgrade
|
Inventory Turnover | 4.63 | 4.67 | 4.28 | 4.41 | 4.73 | 4.95 | Upgrade
|
Quick Ratio | 1.85 | 1.93 | 2.07 | 2.73 | 2.13 | 1.99 | Upgrade
|
Current Ratio | 2.77 | 2.80 | 2.88 | 3.70 | 2.93 | 2.73 | Upgrade
|
Return on Equity (ROE) | 17.42% | 17.71% | 21.32% | 23.34% | 31.59% | 20.20% | Upgrade
|
Return on Assets (ROA) | 10.33% | 9.93% | 11.86% | 13.78% | 15.73% | 10.29% | Upgrade
|
Return on Capital (ROIC) | 12.48% | 12.01% | 14.25% | 16.86% | 19.82% | 12.92% | Upgrade
|
Return on Capital Employed (ROCE) | 19.30% | 19.20% | 22.40% | 24.70% | 28.30% | 18.50% | Upgrade
|
Earnings Yield | 3.22% | 2.08% | 2.28% | 3.36% | 1.91% | 1.65% | Upgrade
|
FCF Yield | 2.12% | 1.17% | 1.59% | 2.52% | 0.95% | 1.42% | Upgrade
|
Dividend Yield | 0.38% | 0.26% | 0.20% | 0.21% | 0.15% | - | Upgrade
|
Payout Ratio | 12.76% | 12.00% | 9.61% | 9.23% | 7.72% | 13.89% | Upgrade
|
Buyback Yield / Dilution | 2.10% | 2.13% | 0.66% | 0.66% | -0.66% | -0.53% | Upgrade
|
Total Shareholder Return | 2.48% | 2.39% | 0.86% | 0.87% | -0.51% | -0.53% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.